Equity Tips

header ads

INDIAN BENCHMARKS: NIFTY FAILS TO HOLD 10450, DIVIS LAB LIFT PHARMA INDEX BY 3%

Equity Tips

Equity benchmarks closed range bound session flat with a negative bias on Thursday after investors digested the outcome of Federal Reserve policy meeting and focused on corporate earnings.
The 30-share BSE Sensex was down 27.05 points at 33,573.22 after intraday swing of around 130 points. PSU banks, FMCG, oil & gas and select auto stocks were under pressure while healthcare stocks and ICICI Bank capped losses.
Divis Labs rallied 17 percent after the company said the US Food and Drug Administration would be lifting the Import Alert 66-40 and moving to close out the warning letter issued to the company's unit-II at Visakhapatnam.

HEADLINES OF THE DAY
Divis Labs spikes as USFDA to lift import ban
Hero MotoCorp down 2% post Jul-Sep earnings
Cadila up 2% after arm gets USFDA nod.

The crucial resistance for Nifty spot is now seen at 10500 and above this 10630.Support for the immediate term is now placed at 10405 and next support will be 10350.

UPCOMING RESULTS: EDELWEISS, HINDALCO, PNB, SCI, TITAN, TORRENTPHARMA, UCOBANK, UNICHEM LAB, UNION BANK, ZENSARTECH

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Post a Comment

0 Comments